Prevention of ovarian hyperstimulation syndrome (OHSS): British Fertility Society policy and practice guideline

被引:1
作者
Tsampras, N. [1 ]
Palinska-Rudzka, K. [2 ]
Alebrahim, Y. [2 ]
Craciunas, L. [3 ]
Mathur, R. [1 ]
机构
[1] Univ Manchester, Sch Med Sci, Dev Biol & Med, Manchester, England
[2] Manchester Univ NHS Fdn Trust, St Marys Hosp, Dept Reprod Med, Manchester, England
[3] Newcastle Fertil Ctr, Int Ctr Life, Biomed West Wing,Times Sq, Newcastle Upon Tyne, England
关键词
Ovarian hyperstimulation syndrome; prevention; assisted reproductive technology; gonadotropins; ovarian stimulation; IN-VITRO FERTILIZATION; FOLLICLE-STIMULATING-HORMONE; ANTI-MULLERIAN HORMONE; FINAL OOCYTE MATURATION; GNRH ANTAGONIST CYCLE; FREEZE-ALL STRATEGY; LIVE BIRTH-RATES; CORIFOLLITROPIN ALPHA; RECOMBINANT FSH; EMBRYO-TRANSFER;
D O I
10.1080/14647273.2024.2441827
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This British Fertility Society (BFS) Policy and Practice guideline aims to support clinicians in preventing ovarian hyperstimulation syndrome (OHSS) in patients undergoing gonadotropin ovarian stimulation. A systematic literature search of the medical databases was performed. The Guideline Development Group (GDG) identified the risk factors of OHSS before and during ovarian stimulation. The relation of different pre-treatment measures and different ovarian stimulation protocols with OHSS was evaluated. The optimal monitoring during treatment was assessed. The current evidence on preventive strategies during and after ovarian stimulation and the available adjuvant preventive agents were examined. Based on this, the GDG developed evidence-based, graded recommendations for clinical practice. The evidence was evaluated within context, considering the effectiveness, cost and practical problems of assisted reproductive technology for patients and healthcare providers. Early identification and application of preventive measures identified in this guideline may reduce the incidence of OHSS or reduce its severity. Suggestions for future research on OHSS prevention are provided.
引用
收藏
页数:20
相关论文
共 108 条
  • [1] Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation
    Aboulghar, MA
    Mansour, RT
    Serour, GI
    Rhodes, CA
    Amin, YM
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2000, 17 (05) : 298 - 301
  • [2] A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS
    Aboulghar, Mohamed A.
    Mansour, Ragaa T.
    Amin, Yahia M.
    Al-Inany, Hesham G.
    Aboulghar, Mona M.
    Serour, Gamal I.
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 15 (03) : 271 - 279
  • [3] Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation
    Aghssa, Malek Mansour
    Tarafdari, Azam Manshadi
    Tehraninejad, Ensieh Shahrokh
    Ezzati, Mohammad
    Bagheri, Maryam
    Panahi, Zahra
    Mahdavi, Saeed
    Abbasi, Mehrshad
    [J]. REPRODUCTIVE HEALTH, 2015, 12
  • [4] Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
    Al-Inany, Hesham G.
    Youssef, Mohamed A.
    Ayeleke, Reuben Olugbenga
    Brown, Julie
    Lam, Wai Sun
    Broekmans, Frank J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [5] Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial
    Andersen, Anders Nyboe
    Nelson, Scott M.
    Fauser, Bart C. J. M.
    Garcia-Velasco, Juan Antonio
    Klein, Bjarke M.
    Arce, Joan-Carles
    [J]. FERTILITY AND STERILITY, 2017, 107 (02) : 387 - +
  • [6] Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model
    Ashrafi, Mahnaz
    Bahmanabadi, Akram
    Akhond, Mohammad Reza
    Arabipoor, Arezoo
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (05) : 1145 - 1152
  • [7] Recombinant follicle stimulating hormone
    Bergh, C
    [J]. HUMAN REPRODUCTION, 1999, 14 (06) : 1418 - 1419
  • [8] Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome
    Bordewijk, Esmee M.
    Ng, Ka Ying Bonnie
    Rakic, Lidija
    Mol, Ben Willem J.
    Brown, Julie
    Crawford, Tineke J.
    van Wely, Madelon
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (02):
  • [9] ESHRE guideline:oval n s simulation for IVF/ICSI
    Bosch, Ernesto
    Broer, Simone
    Griesinger, Georg
    Grynberg, Michael
    Humaidan, Peter
    Kolibianakis, Estratios
    Kunicki, Michal
    La Marca, Antonio
    Lainas, George
    Le Clef, Nathalie
    Massin, Nathalie
    Mastenbroek, Sebastiaan
    Polyzos, Nikolaos
    Sunkara, Sesh Kamal
    Timeva, Tanya
    Toyli, Mira
    Urbancsek, Janos
    Vermeulen, Nathalie
    Broekmans, Frank
    [J]. HUMAN REPRODUCTION OPEN, 2020, 2020 (02)
  • [10] The freeze-all strategy after IVF: which indications?
    Bourdon, Mathilde
    Maignien, Chloe
    Pocate-Cheriet, Khaled
    Bureau, Genevieve Plu
    Marcellin, Louis
    Patrat, Catherine
    Chapron, Charles
    Santulli, Pietro
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2021, 42 (03) : 529 - 545